pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

25,951 catalysts · 16,950 approval · 3,627 device 510k · 2,351 grant · 1,190 device recall · 1,071 device pma · 762 recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 6 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
to 2025-11-03×clear all
type
  • approval16,950
  • device 510k3,627
  • grant2,351
  • device recall1,190
  • device pma1,071
  • recall762
therapy area

no tagged catalysts yet

Week of Sep 22, 2025

50
›Sep 22, 2025grant348d agoMIDWEST RESEARCH INSTITUTE — MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE

CA grant. $3,460,074

full page →nih reporter ↗
›Sep 22, 2025grant348d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Mechanisms of Radiation-induced Hemolysis

ES grant. $340,383. PI: Regina M Day

full page →nih reporter ↗
›Sep 22, 2025grant348d agoWEILL MEDICAL COLL OF CORNELL UNIV — Mechanism and rescue of lysosomal defects in Adult-onset Neuronal Ceroid Lipo...

NS grant. $49,538. PI: Samantha R McDonough

full page →nih reporter ↗
›Sep 22, 2025grant348d agoUNIVERSITY OF CALIFORNIA BERKELEY — Reactivating regulatory programs for regeneration

HL grant. $112,350. PI: Megan Lee Martik

full page →nih reporter ↗
›Sep 22, 2025grant348d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — EMED: An Ethical Mixture-of-Experts Digital Twin Framework for Medical Device...

OD grant. $1,999,996. PI: Hanjie Chen

full page →nih reporter ↗
›Sep 22, 2025grant348d agoCARROLL UNIVERSITY — Influence of a supervised postpartum exercise program on maternal physical ac...

HD grant. $343,320. PI: RITA DEERING

full page →nih reporter ↗
›Sep 22, 2025grant348d agoOHIO STATE UNIVERSITY — Insulin-accelerated surgical approach to pre-retinal gene therapyShanghai Jiao Tong University

EY grant. $206,739. PI: THOMAS ALLAN MENDEL

full page →nih reporter ↗
›Sep 22, 2025grant348d agoNUVOX PHARMA, LLC — Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Thera...NuvOx Pharma LLC

CA grant. $919,366. PI: Katherine Havranek

full page →nih reporter ↗
›Sep 22, 2025grant348d agoEMORY UNIVERSITY — A Phase 2b randomized open label trial to assess the quality and balance of d...Emory University

AI grant. $299,430. PI: Matthew Collins

full page →nih reporter ↗
›Sep 22, 2025grant348d agoUNIVERSITY OF MINNESOTA — In vivo hematopoietic stem cell gene therapy in a novel genetically humanized...University of Minnesota

AI grant. $36,093. PI: Ella Joy Eaton

full page →nih reporter ↗
›Sep 22, 2025grant348d agoCINCINNATI CHILDRENS HOSP MED CTR — Contributions of de novo lipid synthesis to hematopoietic stem cell function

HL grant. $42,479. PI: Sydney Treichel

full page →nih reporter ↗
›Sep 22, 2025grant348d agoCOLUMBIA UNIV NEW YORK MORNINGSIDE — Quantifying Relationships Between Behavior, Neural Network and Metabolic Dysf...

NS grant. $49,538. PI: Kaitlyn Swayze

full page →nih reporter ↗
›Sep 22, 2025grant348d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Co-Designing and Evaluating Additional Mothers and Babies Program Content for...Northwestern University

MH grant. $720,000. PI: HEATHER Jill RISSER

full page →nih reporter ↗
›Sep 22, 2025grant348d agoWESTERN UNIVERSITY OF HEALTH SCIENCES — Training Interprofessional Community-Engaged Research Teams (TICERT)

NR grant. $216,731. PI: Mary Lopez

full page →nih reporter ↗
›Sep 22, 2025grant348d agoCHILDREN'S MERCY HOSP (KANSAS CITY, MO) — Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Train...

AT grant. $753,142. PI: Mark Andrew Connelly

full page →nih reporter ↗
›Sep 22, 2025grant348d agoUNIVERSITY OF TENNESSEE KNOXVILLE — Supporting FDA's Integrated Food Safety System Training Delivery and Development

FD grant. $500,000. PI: Sharon R Thompson

full page →nih reporter ↗
›Sep 22, 2025grant348d agoGLOBAL FOOD PROTECTION INSTITUTE D/B/A INTERNATIONAL FOOD PROTECTION TRAINING INSTITUTE — Supporting the Advancement of FDA's Integrated Food Safety System (IFSS) Trai...

FD grant. $500,000. PI: Craig Kaml

full page →nih reporter ↗
›Sep 22, 2025grant348d agoTOXSTRATEGIES, INC. — Small Molecules and Biologics Toxicology Consultant Support ServicesVincere Biosciences Inc

DA grant. $28,000

full page →nih reporter ↗
›Sep 22, 2025grant348d agoJACKSON LABORATORY — REPOSITORY OF MOUSE MODELS FOR DOWN SYNDROME

HD grant. $649,999. PI: CATHLEEN LUTZ

full page →nih reporter ↗
›Sep 22, 2025grant348d agoJOHNS HOPKINS UNIVERSITY — Galvanic vestibular stimulation: from cellular mechanisms to behavioral respo...Johns Hopkins University

DC grant. $226,958. PI: Gene Yevgeny Fridman

full page →nih reporter ↗
›Sep 22, 2025grant348d agoMERLIN BIOTECH INC — SBIR FY25 Concept Award, Development of an Immunotherapy for Ewing Sarcoma Us...MERLIN Biotech LLC

CA grant. $355,000

full page →nih reporter ↗
›Sep 22, 2025grant348d agoUnknown institution — SUBJECT MATTER EXPERT FOR PROCESS CHEMISTRY DEVELOPMENT

DA grant. $8,460

full page →nih reporter ↗
›Sep 23, 2025approval347d agoCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalJanssen Therapeutics

Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoQUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

full page →fda approvals ↗
›Sep 23, 2025approval347d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗
›Sep 23, 2025approval347d agoLUPRON DEPOT-PED KIT (LEUPROLIDE ACETATE) — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: ABBVIE ENDOCRINE INC. Form: POWDER. Route: INTRAMUSCULAR

full page →fda approvals ↗
›Sep 23, 2025approval347d agoLUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗
›Sep 23, 2025approval347d agoFLAREX (FLUOROMETHOLONE ACETATE) — FDA approvalHARROW, INC.

Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗
›Sep 23, 2025approval347d agoALVIMOPAN — FDA approvalALVIMOPAN

Sponsor: HIKMA. Form: CAPSULE. Route: ORAL

full page →ALVIMOPAN →fda approvals ↗
›Sep 23, 2025approval347d agoJORNAY PM (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: IRONSHORE PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoCIMZIA (CERTOLIZUMAB PEGOL) — FDA approvalcertolizumab pegol

Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION

full page →certolizumab pegol →fda approvals ↗
›Sep 23, 2025approval347d agoTRIPTODUR KIT (TRIPTORELIN PAMOATE) — FDA approvaltriptorelin pamoate ER

Sponsor: AZURITY. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →triptorelin pamoate ER →fda approvals ↗
›Sep 23, 2025approval347d agoDEXEDRINE SPANSULE (DEXTROAMPHETAMINE SULFATE) — FDA approvalMallinckrodt LLC

Sponsor: IMPAX LABS INC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoFOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvaldexmethylphenidate hydrochloride ER

Sponsor: SANDOZ. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →dexmethylphenidate hydrochloride ER →fda approvals ↗
›Sep 23, 2025approval347d agoFENSOLVI KIT (LEUPROLIDE ACETATE) — FDA approvalLEUPROLIDE ACETATE

Sponsor: TOLMAR. Form: POWDER. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗
›Sep 23, 2025approval347d agoTRELSTAR (TRIPTORELIN PAMOATE) — FDA approvaltriptorelin pamoate ER

Sponsor: VERITY. Form: INJECTABLE. Route: INTRAMUSCULAR

full page →triptorelin pamoate ER →fda approvals ↗
›Sep 23, 2025approval347d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

Sponsor: ABHAI LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
›Sep 23, 2025approval347d agoLEUPROLIDE ACETATE — FDA approvalInvaGen Pharmaceuticals Inc

Sponsor: SUN PHARM. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗
›Sep 23, 2025approval347d agoMETHYLPHENIDATE HYDROCHLORIDE — FDA approvalMETHYLPHENIDATE HYDROCHLORIDE

Sponsor: ALVOGEN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →METHYLPHENIDATE HYDROCHLORIDE →fda approvals ↗
›Sep 23, 2025approval347d agoRELEXXII (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoALVIMOPAN — FDA approvalPar Pharmaceutical Inc

Sponsor: WATSON LABS TEVA. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoZOLADEX (GOSERELIN ACETATE) — FDA approvalgoserelin LA

Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION

full page →goserelin LA →fda approvals ↗
›Sep 23, 2025approval347d agoPRIMIDONE — FDA approvalFrontida Biopharm Inc

Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoDAYTRANA (METHYLPHENIDATE) — FDA approvalNoven Pharmaceuticals Inc

Sponsor: NOVEN PHARMS INC. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL

full page →fda approvals ↗
›Sep 23, 2025approval347d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: AMNEAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗
›Sep 23, 2025approval347d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: SANDOZ. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗
›Sep 23, 2025approval347d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
›Sep 23, 2025approval347d agoLEUPROLIDE ACETATE — FDA approvalLEUPROLIDE ACETATE

Sponsor: UBI. Form: SOLUTION. Route: SUBCUTANEOUS

full page →LEUPROLIDE ACETATE →fda approvals ↗
← prev
page 470 of 520
next →
$COLL23.86-1.81%
$AMRX17.87-1.05%
$COLL23.86-1.81%
$COLL23.86-1.81%
$AMRX17.87-1.05%
$COLL23.86-1.81%
$HROW38.26-2.02%